GlaxoSmithKline
This article was originally published in The Tan Sheet
Executive Summary
Firm is proposing to close three former Block Drug consumer health care product manufacturing sites in Puerto Rico, UK, Ireland over next two years. Operations at these sites are duplicated elsewhere in GSK's network, company says, and can be incorporated into GSK facilities in UK, U.S. Three sites manufacture dental products such as Sensodyne, Poli-Grip, Polident and other smaller brands. GSK completed its purchase of Block in January (1"The Tan Sheet" Jan. 22, In Brief). Block's products eventually will bear GSK name